Very Low Incidence of SARS-CoV-2, Influenza and RSV but High Incidence of Rhino-, Adeno- and Endemic Coronaviruses in Children With Acute Respiratory Infection in Primary Care Pediatric Practices During the Second and Third Wave of the SARS-CoV-2 Pandemic.

"A.S. received research grants, speaker’s fees and/or fees for participation in advisory board meetings and travelling grants from GlaxoSmithKline, Pfizer Pharma, Janssen-Cilag and MSD. J.G.L. received research grants, speaker’s fees and fees for participation in advisory board meetings from GlaxoSmithKline, Pfizer Pharma, Janssen-Cilag, SPMSD and MSD. The other authors have no conflicts of interest to disclose."

"A.S. received research grants, speaker’s fees and/or fees for participation in advisory board meetings and travelling grants from GlaxoSmithKline, Pfizer Pharma, Janssen-Cilag and MSD. J.G.L. received research grants, speaker’s fees and fees for participation in advisory board meetings from GlaxoSmithKline, Pfizer Pharma, Janssen-Cilag, SPMSD and MSD. The other authors have no conflicts of interest to disclose. J.S., K.H. and J.G.L. designed the study. J.S. collected the data, performed the analysis and interpreted the data. G.E. supported the analysis, interpreted the data and drafted the manuscript. K.H. supported the collection, analysis and interpreted the data. A.S. and J.G.L. supervised the study conduct, supported data analysis and interpretation. K.K. and B.W. performed multiplex-PCR and subtyping on laboratory specimens and analyzed the virologic results. L.D. and C.H. supported the study conduct and the data interpretation. All authors read, revised and approved the final manuscript."